| 7.25 0.06 (0.83%) | 09-10 16:00 | |||||||||||||
|
|
| Short term |  |
|||
| Mid term |  |
|||
| Targets | 6-month : | 8.85 | 1-year : | 9.44 |
| Resists | First : | 7.57 | Second : | 8.08 |
| Pivot price | 7.27  |
|||
| Supports | First : | 6.76 | Second : | 5.62 |
| MAs | MA(5) : | 7.41  |
MA(20) : | 7.21 |
| MA(100) : | 9.93 |
MA(250) : | 14.82 |
|
| MACD | MACD : | -0.3 |
Signal : | -0.4 |
| %K %D | K(14,3) : | 42 |
D(3) : | 56.7 |
| RSI | RSI(14): 43.4 |
|||
| 52-week | High : | 22.54 | Low : | 6.76 |
Price has closed below its short-term moving average. Short-term moving average is currently below mid-term; and below long-term moving average. From the relationship between price and moving averages: This stock is BEARISH in short-term; and BEARISH in mid-long term.[ TDOC ] has closed above bottom band by 47.0%. Bollinger Bands are 58.3% narrower than normal. The narrow width of the bands suggests low volatility as compared to its normal range. The bands have been in this narrow range for 12 bars. This is a sign that the market may be about to initiate a new trend.
| If tomorrow: | Open lower | Open higher |
| High: | 7.3 - 7.34 | 7.34 - 7.37 |
| Low: | 7 - 7.04 | 7.04 - 7.07 |
| Close: | 7.19 - 7.25 | 7.25 - 7.31 |
Teladoc Health, Inc. provides virtual healthcare services in the United States and internationally. The company offers a portfolio of services and solutions covering non-urgent, episodic, chronic, and complicated medical conditions, including diabetes, hypertension, chronic kidney disease, cancer, congestive heart failure, and mental health conditions. It offers a range of programs and services, including primary and specialty care telehealth solutions, chronic condition management, expert medical services, mental health solutions, and platform and program services. The company serves employers, health plans, hospitals and health systems, and insurance and financial services companies, as well as individual members. It offers its products and services under the Teladoc, Livongo, and BetterHelp brands. The company was formerly known as Teladoc, Inc. and changed its name to Teladoc Health, Inc. in August 2018. The company was incorporated in 2002 and is headquartered in Purchase, New York.
Tue, 10 Sep 2024
Teladoc Stock Near 52-Week Low: Is it Healthy Enough to Invest? - Zacks Investment Research
Tue, 10 Sep 2024
Monaco Asset Management SAM Purchases Shares of 125,000 Teladoc Health, Inc. (NYSE:TDOC) - MarketBeat
Mon, 09 Sep 2024
Teladoc Health (NYSE:TDOC) Stock Price Down 4.9% - MarketBeat
Sun, 08 Sep 2024
Teladoc Health, Inc. (TDOC): Among the Worst ARK Stocks According to Short Sellers - Insider Monkey
Sun, 08 Sep 2024
Teladoc Health, Inc. (TDOC): Among the Worst ARK Stocks According to Short Sellers - Yahoo Finance
Fri, 06 Sep 2024
Teladoc Health Announces Employee Inducement Award under NYSE Rule 303A.08 - StockTitan
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Outperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Outperform |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Healthcare
|
|
|
Industry:
Medical - Healthcare Information Services
|
|
| Shares Out | 171 (M) |
| Shares Float | 170 (M) |
| Held by Insiders | 0.8 (%) |
| Held by Institutions | 81.7 (%) |
| Shares Short | 29,210 (K) |
| Shares Short P.Month | 34,880 (K) |
| EPS | -5.97 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 8.77 |
| Profit Margin | -38.6 % |
| Operating Margin | -7.7 % |
| Return on Assets (ttm) | -3.5 % |
| Return on Equity (ttm) | -53 % |
| Qtrly Rev. Growth | -1.5 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 15.24 |
| EBITDA (p.s.) | 0.38 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 333 (M) |
| Levered Free Cash Flow | 274 (M) |
| PE Ratio | -1.22 |
| PEG Ratio | 0 |
| Price to Book value | 0.82 |
| Price to Sales | 0.47 |
| Price to Cash Flow | 3.72 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|